Thus, our results in Figure 5E,F consolidated the standpoint that HNSCC patients with higher COL3A1 expression generally possessed a relatively suppressed condition of immune cells owing to low‐level TNFRSF18 and TNFRSF25. The gene discussed is COL3A1; the disease is head and neck squamous cell carcinoma.